SFR2-6-20: ev3 Solitaire 2 Revascularization Device: 6mm x 20mm x 180cm
Sign in to add this product to your favorites!
Price: | $1,058.50 per box of 1 |
---|---|
Quantity: | |
In Stock: | 15 box of 1 |
Status: | expired |
Additional Details
ev3 Solitaire Revascularization Device
The Solitaire™ Revascularization Device is indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large vessel occlusion, and smaller core infarcts who have first received intravenous tissue plasminogen activator (IV t-PA). Endovascular therapy with the device should be started within 6 hours of symptom onset.
The Solitaire™ Revascularization Device is indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for IV t-PA or who fail IV t-PA therapy are candidates for treatment.